Literature DB >> 28775122

Circulating microRNA expressions can predict the outcome of lenalidomide plus low-dose dexamethasone treatment in patients with refractory/relapsed multiple myeloma.

Seung-Hyun Jung1,2, Sung-Eun Lee3, Minho Lee2, So-Hee Kim4, Seon-Hee Yim4, Tae Woo Kim3, Chang-Ki Min5,6, Yeun-Jun Chung7,4,8.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28775122      PMCID： PMC5664408          DOI： 10.3324/haematol.2017.168070

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

1.  Better quality of response to lenalidomide plus dexamethasone is associated with improved clinical outcomes in patients with relapsed or refractory multiple myeloma.

Authors:  Jean-Luc Harousseau; Meletios A Dimopoulos; Michael Wang; Alessandro Corso; Christine Chen; Michel Attal; Andrew Spencer; Zhinuan Yu; Marta Olesnyckyj; Jerome B Zeldis; Robert D Knight; Donna M Weber
Journal:  Haematologica       Date:  2010-05-11       Impact factor: 9.941

2.  MicroRNA-193a represses c-kit expression and functions as a methylation-silenced tumor suppressor in acute myeloid leukemia.

Authors:  X-N Gao; J Lin; Y-H Li; L Gao; X-R Wang; W Wang; H-Y Kang; G-T Yan; L-L Wang; L Yu
Journal:  Oncogene       Date:  2011-03-14       Impact factor: 9.867

3.  Identification of MLL-fusion/MYC⊣miR-26⊣TET1 signaling circuit in MLL-rearranged leukemia.

Authors:  Hao Huang; Xi Jiang; Jinhua Wang; Yuanyuan Li; Chun-Xiao Song; Ping Chen; Shenglai Li; Sandeep Gurbuxani; Stephen Arnovitz; Yungui Wang; Hengyou Weng; Mary Beth Neilly; Chuan He; Zejuan Li; Jianjun Chen
Journal:  Cancer Lett       Date:  2016-01-11       Impact factor: 8.679

4.  miR-30-5p functions as a tumor suppressor and novel therapeutic tool by targeting the oncogenic Wnt/β-catenin/BCL9 pathway.

Authors:  Jian-Jun Zhao; Jianhong Lin; Di Zhu; Xujun Wang; Daniel Brooks; Ming Chen; Zhang-Bo Chu; Kohichi Takada; Bryan Ciccarelli; Samir Admin; Jianguo Tao; Yu-Tzu Tai; Steven Treon; Geraldine Pinkus; Winston Patrick Kuo; Teru Hideshima; Mary Bouxsein; Nikhil Munshi; Kenneth Anderson; Ruben Carrasco
Journal:  Cancer Res       Date:  2014-03-05       Impact factor: 12.701

5.  Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group.

Authors:  Antonio Palumbo; Hervé Avet-Loiseau; Stefania Oliva; Henk M Lokhorst; Hartmut Goldschmidt; Laura Rosinol; Paul Richardson; Simona Caltagirone; Juan José Lahuerta; Thierry Facon; Sara Bringhen; Francesca Gay; Michel Attal; Roberto Passera; Andrew Spencer; Massimo Offidani; Shaji Kumar; Pellegrino Musto; Sagar Lonial; Maria T Petrucci; Robert Z Orlowski; Elena Zamagni; Gareth Morgan; Meletios A Dimopoulos; Brian G M Durie; Kenneth C Anderson; Pieter Sonneveld; Jésus San Miguel; Michele Cavo; S Vincent Rajkumar; Philippe Moreau
Journal:  J Clin Oncol       Date:  2015-08-03       Impact factor: 44.544

6.  Low serum miR-19a expression as a novel poor prognostic indicator in multiple myeloma.

Authors:  Mu Hao; Meirong Zang; Erik Wendlandt; Yan Xu; Gang An; Dasen Gong; Fei Li; Fang Qi; Yanru Zhang; Ye Yang; Fenghuang Zhan; Lugui Qiu
Journal:  Int J Cancer       Date:  2014-09-19       Impact factor: 7.396

7.  Circulating serum microRNAs as novel diagnostic and prognostic biomarkers for multiple myeloma and monoclonal gammopathy of undetermined significance.

Authors:  Lenka Kubiczkova; Fedor Kryukov; Ondrej Slaby; Elena Dementyeva; Jiri Jarkovsky; Jana Nekvindova; Lenka Radova; Henrieta Greslikova; Petr Kuglik; Eva Vetesnikova; Ludek Pour; Zdenek Adam; Sabina Sevcikova; Roman Hajek
Journal:  Haematologica       Date:  2013-11-15       Impact factor: 9.941

8.  Evaluation of the Revised International Staging System in an independent cohort of unselected patients with multiple myeloma.

Authors:  Efstathios Kastritis; Evangelos Terpos; Maria Roussou; Maria Gavriatopoulou; Magdalini Migkou; Evangelos Eleutherakis-Papaiakovou; Despoina Fotiou; Dimitrios Ziogas; Ioannis Panagiotidis; Eftychia Kafantari; Stavroula Giannouli; Athanasios Zomas; Konstantinos Konstantopoulos; Meletios A Dimopoulos
Journal:  Haematologica       Date:  2016-10-27       Impact factor: 9.941

9.  Circulating miRNA markers show promise as new prognosticators for multiple myeloma.

Authors:  A Rocci; C C Hofmeister; S Geyer; A Stiff; M Gambella; L Cascione; J Guan; D M Benson; Y A Efebera; T Talabere; V Dirisala; E M Smith; P Omedè; G Isaia; L De Luca; D Rossi; S Gentili; G Uccello; J Consiglio; R Ria; G Benevolo; S Bringhen; V Callea; B Weiss; A Ferro; V Magarotto; H Alder; J C Byrd; M Boccadoro; G Marcucci; A Palumbo; F Pichiorri
Journal:  Leukemia       Date:  2014-05-12       Impact factor: 11.528

10.  MicroRNA-26a-5p and microRNA-23b-3p up-regulate peroxiredoxin III in acute myeloid leukemia.

Authors:  Wenjie Jiang; Jie Min; Xiaohui Sui; Yanyan Qian; Ying Liu; Zhaojian Liu; Haibin Zhou; Xi Li; Yaoqin Gong
Journal:  Leuk Lymphoma       Date:  2014-06-25
View more
  10 in total

Review 1.  The power of microRNAs as diagnostic and prognostic biomarkers in liquid biopsies.

Authors:  Lorena Quirico; Francesca Orso
Journal:  Cancer Drug Resist       Date:  2020-02-21

Review 2.  A Challenge to Aging Society by microRNA in Extracellular Vesicles: microRNA in Extracellular Vesicles as Promising Biomarkers and Novel Therapeutic Targets in Multiple Myeloma.

Authors:  Tomofumi Yamamoto; Nobuyoshi Kosaka; Yutaka Hattori; Takahiro Ochiya
Journal:  J Clin Med       Date:  2018-03-12       Impact factor: 4.241

Review 3.  The Non-Coding RNA Landscape of Plasma Cell Dyscrasias.

Authors:  Eugenio Morelli; Annamaria Gullà; Roberta Rocca; Cinzia Federico; Lavinia Raimondi; Stefano Malvestiti; Valter Agosti; Marco Rossi; Giosuè Costa; Gianluca Giavaresi; Kareem A Azab; Antonia Cagnetta; Michele Cea; Pierosandro Tagliaferri; Antonino Neri; Nikhil C Munshi; Giuseppe Viglietto; Pierfrancesco Tassone; Nicola Amodio
Journal:  Cancers (Basel)       Date:  2020-01-30       Impact factor: 6.639

Review 4.  Potential Therapeutic Roles of Exosomes in Multiple Myeloma: A Systematic Review.

Authors:  Mengzhen Li; Bing Xia; Yi Wang; M James You; Yizhuo Zhang
Journal:  J Cancer       Date:  2019-10-15       Impact factor: 4.207

5.  Association of DNA repair genes polymorphisms with childhood acute lymphoblastic leukemia: a high-resolution melting analysis.

Authors:  Shahrzad Zehtab; Mahla Sattarzadeh Bardsiri; Roohollah Mirzaee Khalilabadi; Mohsen Ehsan; Ahmad Fatemi
Journal:  BMC Res Notes       Date:  2022-02-14

Review 6.  The future of myeloma precision medicine: integrating the compendium of known drug resistance mechanisms with emerging tumor profiling technologies.

Authors:  Taylor Harding; Linda Baughn; Shaji Kumar; Brian Van Ness
Journal:  Leukemia       Date:  2019-01-25       Impact factor: 11.528

Review 7.  Targeting microRNA in hematologic malignancies.

Authors:  Zhen Han; Steven T Rosen; Christiane Querfeld
Journal:  Curr Opin Oncol       Date:  2020-09       Impact factor: 3.915

Review 8.  Circulating microRNAs and Their Role in Multiple Myeloma.

Authors:  Cinzia Federico; Antonio Sacco; Angelo Belotti; Rossella Ribolla; Valeria Cancelli; Arianna Giacomini; Roberto Ronca; Marco Chiarini; Luisa Imberti; Mirella Marini; Giuseppe Rossi; Marco Presta; Bruno Paiva; Aldo M Roccaro
Journal:  Noncoding RNA       Date:  2019-05-02

Review 9.  Liquid biopsies for multiple myeloma in a time of precision medicine.

Authors:  Bruna Ferreira; Joana Caetano; Filipa Barahona; Raquel Lopes; Emilie Carneiro; Bruno Costa-Silva; Cristina João
Journal:  J Mol Med (Berl)       Date:  2020-04-04       Impact factor: 4.599

10.  Circulating miRNAs as Auxiliary Diagnostic Biomarkers for Multiple Myeloma: A Systematic Review, Meta-Analysis, and Recommendations.

Authors:  Yunhui Xiang; Liuyun Zhang; Pinpin Xiang; Juan Zhang
Journal:  Front Oncol       Date:  2021-07-08       Impact factor: 6.244
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.